Healthpeak Properties: Can This Healthcare REIT Keep Funding Its Dividend
Healthpeak Properties (DOC) declared monthly dividends totaling $1.22004 annually, with a 6.48% yield. Shares fell 8.36% to $18.83. Q2 2026 revenue was $310.67M for outpatient, $216.11M for lab, and senior housing showed growth. FFO guidance is $1.73-$1.77, covering the dividend. Asset sales and recapitalizations raised $1.75B. Peers Welltower (WELL) and Ventas (VTR) raised dividends. DOC's payout ratio is 69.7% at midpoint. Interest expenses rose to $92.3M.
How this was made

The 30-second read
Why it matters
The new FFO guidance and dividend policy are the first disclosed figures for FY2026, offering fresh data for valuation models.
Market read
Provides actionable insight for REIT investors evaluating dividend sustainability and cash‑flow coverage.
What to watch
The recent $1.025B asset sale to Brookfield and upcoming $500M buyback provide additional cash that may offset guidance shortfalls.
Background
Healthpeak Properties is a diversified healthcare REIT with exposure to outpatient facilities, labs, and senior housing.
Ticker impact
Healthpeak Properties disclosed 2026 FFO guidance of $1.73‑$1.77 per share and monthly dividend details, a fresh corporate update.
potential downside pressure if FY2026 FFO guidance falls below $1.73; limited upside unless guidance is raised.
The dividend coverage ratio is 69.7% at midpoint; investors will watch guidance closely. Current liquidity is strong, but rising interest expense adds risk.
Market effects
Highlights dividend sustainability concerns for healthcare REITs, may prompt peers to review payout ratios.
U.S. REIT sector may see modest re‑rating as investors assess cash‑flow coverage.
Limited; primarily affects U.S. healthcare real‑estate investors.
Counterpoint
Despite higher interest costs, the $3B+ liquidity cushion and senior‑housing growth could support the stock longer than implied.
Key entities
- CompanyHealthpeak Properties
Healthcare REIT issuing the guidance.
- CompanyBrookfield
Buyer of a 49% stake in an outpatient portfolio.

